Laura Lombardero
Leioa, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cognitive improvement via cortical cannabinoid receptors and choline-containing lipids.
Journal: British journal of pharmacology
Published: March 07, 2024
Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion.
Journal: ACS pharmacology & translational science
Published: April 11, 2022
Enzyme Therapy: Current Challenges and Future Perspectives.
Journal: International journal of molecular sciences
Published: July 31, 2021
Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: May 26, 2021
Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease.
Journal: Journal of neuroinflammation
Published: November 14, 2020
Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: June 06, 2018
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease.
Journal: Neuroscience
Published: March 15, 2016
Effects of galanin subchronic treatment on memory and muscarinic receptors.
Journal: Neuroscience
Published: October 15, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026